The NCI alliance for nanotechnology in cancer: Achievement and path forward

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 2, Issue 5, 2010, Pages 450-460

  Ptak, Krzysztof ^a   Farrell, Dorothy ^a   Panaro, Nicholas J ^b   Grodzinski, Piotr ^a   Barker, Anna D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CAMPTOTHECIN; CYTARABINE; FLUDARABINE; GEMCITABINE; GOLD NANOPARTICLE; NANOMATERIAL; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

BIOCOMPATIBILITY; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RESEARCH; CELL ADHESION; CLINICAL TRIAL; DNA BARCODING; HUMAN; MOLECULAR IMAGING; NANOMEDICINE; NATIONAL HEALTH ORGANIZATION; NEOPLASM; NONHUMAN; NOTE; PRIORITY JOURNAL; TOMOGRAPHY; TOXICOLOGY;

DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; NANOTECHNOLOGY; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; UNITED STATES;

EID: 78449305865     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.98     Document Type: Note

References (43)

1. Ferrari M,. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5: 161-71.
2. Nie S, Xing Y, Kim GJ, Simons JW,. Nanotechnology applications in cancer. Annu Rev Biomed Eng 2007, 9: 257-288.
3. Davis ME, Chen ZG, Shin DM,. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7: 771-82.
4. Heath JR, Davis ME,. Nanotechnology and cancer. Annu Rev Med 2008, 59: 251-65.
5. Singhal S, Nie S, Wang MD,. Nanotechnology applications in surgical oncolog. Annu Rev Med 2010, 61: 359-73.
6. Canelas DA, Herlihy KP, DeSimone JM,. Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. Wiley Interdiscip Rev: Nanomed Nanobiotechnol 2009, 1: 391-404.
7. Kelly JY, DeSimone JM,. Shape-specific, monodisperse nano-molding of protein particles. J Am Chem Soc 2008, 130: 5438-9.
8. Gratton SE, Pohlhaus PD, Lee J, Guo J, Cho MJ, Desimone JM,. Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of print nanoparticles. J Control Release 2007, 121: 10-8.
9. Park JH, von Maltzahn G, Zhang L, Schwartz MP, Ruoslahti E, Bhatia SN, Sailor MJ,. Magnetic iron oxide nanoworms for tumor targeting and imaging. Adv Mater 2008, 20: 1589.
10. Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Girard OM, Hanahan D, Mattrey RF, Ruoslahti E,. Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 2009, 16: 510-520.
11. Park JH, von Maltzahn G, Zhang L, Derfus AM, Simberg D, Harris TJ, Ruoslahti E, Bhatia SN, Sailor MJ,. Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small 2009, 5: 694-700.
12. Park J-H, von Maltzahn G, Xu MJ, Fogal V, Kotamraju VR, Ruoslahti E, Bhatia SN, Sailor MJ,. Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Nat Acad Sci U S A 2009, 107: 981-986.
13. Fulci G, Breymann L, Gianni D, Kurozomi K, Rhee SS, Yu J, Kaur B, Louis DN, Weissleder R, Caligiuri MA, et al. Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proc Nat Acad Sci U S A 2006, 103: 12873-12878. (Pubitemid 44298654)
14. Kelly KA, Bardeesy N, Anbazhagan R, Gurumurthy S, Berger J, Alencar H, Depinho RA, Mahmood U, Weissleder R,. Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med 2008, 5: e85.
15. Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, Young NP, Nielsen GP, Quade BJ, Chaber CJ, Schultz CP, et al. A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med 2007, 13: 992-997.
16. Weissleder R, Pittet MJ,. Imaging in the era of molecular oncology. Nature 2008, 452: 580-589.
17. Goluch ED, Nam JM, Georganopoulou DG, Chiesl TN, Shaikh KA, Ryu KS, Barron AE, Mirkin CA, Liu C,. A bio-barcode assay for on-chip attomolar-sensitivity protein detection. Lab Chip 2006, 6: 1293-1299.
18. Thaxton CS, Daniel WL, Giljohann DA, Thomas AD, Mirkin CA,. Templated spherical high density lipoprotein nanoparticles. J Am Chem Soc 2009, 131: 1384-1385.
19. Agnew HD, Rohde RD, Millward SW, Nag A, Yeo WS, Hein JE, Pitram SM, Tariq AA, Burns VM, Krom RJ, et al. Iterative in situ click chemistry creates antibody-like protein-capture agents. Angew Chem Intl Ed Engl 2009, 48: 4944-8.
20. Fan R, Vermesh O, Srivastava A, Yen BKH, Qin LD, Ahmad H, Kwong GA, Liu CC, Gould J, Hood L, et al. Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat Biotech 2008, 26: 1373-1378.
21. Zavaleta CL, Smith BR, Walton I, Doering W, Davis G, Shojaei B, Natan MJ, Gambhir SS,. Multiplexed imaging of surface enhanced raman scattering nanotags in living mice using noninvasive raman spectroscopy. Proc Nat Acad Sci U S A 2009, 106: 13511-6.
22. De la Zerda A, Zavaleta C, Keren S, Vaithilingam S, Bodapati S, Liu Z, Levi J, Smith BR, Ma TJ, Oralkan O, et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 2008, 3: 557-562.
23. Calderon-Colon X, Geng H, Gao B, An L, Cao G, Zhou O,. A carbon nanotube field emission cathode with high current density and long-term stability. Nanotechnology 2009, 20: 325707.
24. Qian X, Zhou X, Nie S,. Surface-enhanced raman nanoparticle beacons based on bioconjugated gold nanocrystals and long range plasmonic coupling. J Am Chem Soc 2008, 130: 14934-5.
25. Smith AM, Mohs AM, Nie S,. Tuning the optical and electronic properties of colloidal nanocrystals by lattice strain. Nat Nanotechnol 2009, 4: 56-63.
26. Duan H, Nie S,. Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. JACS 2007, 129: 3333-3338.
27. Majoros IJ, Williams CR, Baker JR,. Current dendrimer applications in cancer diagnosis and therapy. Curr Top Med Chem 2008, 8: 1165-1179.
28. Shi X, Wang SH, Swanson SD, Ge S, Cao Z, Van Antwerp ME, Landmark KJ, Baker JR,. Dendrimer-functionalized shell-crosslinked iron oxide nanoparticles for in vivo magnetic resonance imaging of tumors. Adv Mat 2008, 20: 1671-1678.
29. Olson ES, Aguilera TA, Jiang T, Ellies LG, Nguyen QT, Wong EH, Grossaf LA, Tsien RY,. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr. Biol 2009, 1: 382-393.
30. Davis M,. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharma 2009, 6: 659-668.
31. Davis M,. Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin. Adv Drug Delivery Rev 2009, 61: 1189-1192.
32. Schluep T, Hwang J, Hildebrandt IJ, Czernin J, Choi CH, Alabi CA, Mack BC, Davis ME,. Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements. Proc Nat Acad Sci U S A 2009, 106: 11394-11399.
33. 18F]-labeled 2′-deoxycytidine analog. Nat Med 2008, 14: 783-788.
34. Tumeh PC, Radu CG, Ribas A,. PET imaging of cancer immunotherapy. J Nucl Med 2008, 49: 865-868.
35. Laing RE, Walter MA, Campbell DO, Herschman HR, Satyamurthy N, Phelps ME, Czernin J, Witte ON, Radu CG,. Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography. Proc Nat Acad Sci U S A 2009, 106: 2847-2852.
36. Lijowski M, Caruthers S, Hu G, Zhang H, Scott MJ, Williams T, Erpelding T, Schmieder AH, Kiefer G, Gulyas G, et al. High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the vx2 model. Invest Radiol 2009, 44: 15-22.
37. Winter PM, Schmieder AH, Caruthers SD, Keene JL, Zhang H, Wickline SA, Lanza GM,. Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair vx-2 tumor angiogenesis and development in rabbits. FASEB J 2008, 22: 2758-2767.
38. Schmieder AH, Caruthers SD, Zhang H, Williams TA, Robertson JD, Wickline SA, Lanza GM,. Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the mda-mb-435 xenograft mouse model. FASEB J 2008, 22: 4179-4189.
39. Salvador-Morales C, Gao W, Ghatalia P, Murshed F, Aizu W, Langer R, Farokhzad OC,. Multifunctional nanoparticles for prostate cancer therapy. Expert Rev Anticancer Ther 2009, 9: 211-221.
40. Zhang L, Gu F, Chan J, Wang A, Langer R, Farokhzad O,. Nanoparticles in medicine: Therapeutic applications and developments. Clin Pharmacol Therap 2008, 83: 761-769.
41. Veiseh O, Sun C, Fang C, Bhattarai N, Gunn J, Kievit F, Du K, Pullar B, Lee D, Ellenbogen RG, et al. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res 2009, 69: 6200-6207.
42. Veiseh O, Gunn JW, Kievit FM, Sun C, Fang C, Lee JS, Zhang M,. Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small 2009, 5: 256-264.
43. Sun C, Veiseh O, Gunn J, Fang C, Hansen S, Lee D, Sze R, Ellenbogen RG, Olson J, Zhang M,. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 2008, 4: 372-379.